# Novavax Inc: Form 8-K, filed Jun 24, 2025

- Company: [Novavax Inc](/companies/nvax.md) (CIK 1000694)
- Form: 8-K
- Filed: 2025-06-24
- Accepted by EDGAR: Jun 24, 2025, 06:03 ET
- Period: 2025-06-20
- Accession: 0001104659-25-061874
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1000694/000110465925061874/tm2518733d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1000694/000110465925061874/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1000694/000110465925061874/tm2518733d1_8k.htm

Filed Jun 24, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-061874. Last ingested by Listed: Nov 5, 2026, 12:23 ET. No prices; not investment advice.